Feasibility and safety of minimally invasive R1 vascular surgery for hepatocellular carcinoma: a cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034789

Enrollment

Registered

2024-07-29

Start date

2024-06-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22

Interventions

Group 1: Minimally invasive R1vascular hepatectomy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients were eligible for inclusion if they were aged 18 years or older, underwent a curative, minimally invasive parenchymal-sparing hepatectomy for HCC, and had adequate preoperative imaging, including contrast-enhanced computed tomography (CT) and/or magnetic resonance imaging (MRI).

Exclusion criteria

Exclusion criteria: Missing preoperative imaging non curative resections

Design outcomes

Primary

Measure	Time frame
Postoperative complications, stratified according to the Clavien-Dindo (CD) classification	—

Secondary

Measure	Time frame
- Operative characteristics (lenght of operation, extent of resection, blood loss, previous hepatic resection) - Postoperative parameters (lenght of stay, postoperative intervention, postoperative mortality)	—

Countries

Germany

Contacts

Public ContactSchaima Abdelhadi

Chirurgusche Klinik, Universitätsmedizin Mannheim

schaima.abdelhadi@umm.de06213832225

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026